Cash From Operating Activities - Arcellx Inc (NASDAQ:ACLX) - Alpha Spread
A

Arcellx Inc
NASDAQ:ACLX

Watchlist Manager
Arcellx Inc
NASDAQ:ACLX
Watchlist
Price: 86.61 USD 1.38% Market Closed
Market Cap: 4.6B USD
Have any thoughts about
Arcellx Inc?
Write Note

Arcellx Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcellx Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
Arcellx Inc
NASDAQ:ACLX
Cash from Operating Activities
$207.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$18.6B
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$7.5B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$6.4B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
-$944m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.1B
CAGR 3-Years
21%
CAGR 5-Years
12%
CAGR 10-Years
18%

See Also

What is Arcellx Inc's Cash from Operating Activities?
Cash from Operating Activities
207.6m USD

Based on the financial report for Dec 31, 2023, Arcellx Inc's Cash from Operating Activities amounts to 207.6m USD.

Back to Top